BeStock  
Markets › Compare › URGN vs NTLA

URGN vs NTLA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
URGN · UroGen Pharma Ltd$27.65 ▼ 12.86%
NTLA · Intellia Therapeutics$10.00 ▲ 5.04%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5496138181223Nov 24, '25May 26, '26Nov 20, '26
  • URGN +2.7%
  • NTLA +19.8%

Head to head

MetricURGNNTLA
Price$27.65$10.00
Change today▼ 12.86%▲ 5.04%
Market cap$1.36B$1.40B
Return, 3 months-40.1%-20.4%
Return, year to date+18.1%+11.2%
Return, 1 year+6.9%+21.8%
P/E (TTM)––
P/B-10.82.3
P/E percentile vs own 5y4th78th
Dividend yield––
Revenue growth (YoY, latest qtr)+223.9%-48.0%
Net profit growth (YoY)+95.6%-25.8%
Gross margin91.4%–
Operating margin-12.4%-821.2%
Net margin-26.3%-805.7%
Return on equity–-62.6%
Analyst target vs. price+125.0%+92.0%
Analyst buy share100%36%
RSI (14)4041
30-day volatility89.8%77.8%
Max drawdown, 1 year-50.8%-46.6%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyHold

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • NTLA is the largest of the group by market value.
  • NTLA has returned the most over the past year.
  • URGN is growing revenue fastest.
  • URGN keeps the most profit per dollar of sales.
  • NTLA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top